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1. Summary 
The Mongolian influenza surveillance system has gradually improved over the last four 
decades since its beginning in 1970s. Longitudinal analyses of surveillance data from 
different perspectives can provide deeper insight in understanding the extent and long 
term impact of influenza. The current study was aimed to investigate the disease burden 
and epidemiological characteristics of influenza by analyzing the available data collected 
from the ongoing national influenza like illness (ILI) and severe acute respiratory 
infection (sARI) surveillance in Mongolia.  
In this study, both the weekly ILI and sARI surveillance data from the 2007/8 to 2013/14 
influenza seasons were included. The surveillance data included the number of patients 
with ILI, total visits to outpatient clinics, the number of patients with sARI, total 
admissions to hospitals, the number of laboratory-confirmed influenza cases by virus 
type/subtype, and the number of specimens tested from the sentinel sites located in 
seven provinces (locally known as aimags) and Ulaanbaatar city. For laboratory testing, 
nasopharyngeal swabs were collected from selected patients with ILI and sARI per site 
and per week for the entire year and tested using real time-reverse transcription-
polymerase chain reaction (rt-RT-PCR). Selected samples negative for influenza were 
tested for other respiratory pathogens including respiratory syncytial virus (RSV), 
rhinovirus (RV), parainfluenza virus (hPIV), and human metapneumovirus (hMPV) by 
multiplex rt-RT-PCR. The spatio-temporal spreads of seasonal and pandemic influenza 
were mapped for the study periods. 
During the seven influenza seasons, ILI cases occupied 1,797,655 (5.1%) out of total 
35,572,137 outpatient visits and the average incidence rate was 14.6 per 100 population. 
The overall ILI incidence rate was highest in the 2009/10 season (22.2 per 100 
population) and the lowest incidence rate was in the 2008/9 (8.9 per 100 population). 
The overall ILI incidence rate for the seven seasons was highest among those aged less 
than 5 years (86.0 per 100 population) and lowest in the age group of 25─44 years (2.5 
per 100 population). 
A total of 106,003 sARI patients were recorded. The overall sARI incidence rate for the 
seven seasons was calculated to be 0.9 per 100 population. The highest rate was in 
2013/14 season (1.2 per 100 population), whereas the lowest rate was in 2008/9 season 
(0.5 per 100 population). The highest rate was observed in those aged less than 5 years 
for all seasons with the overall rate of 6.9 per 100 population. The rates were much 
lower in other age groups with the lowest rate of 0.1 per 100 population in those aged 
20─49 years.  
During the study period, a total of 22,582 (1.3%) specimens from ILI cases were tested 
and the overall positive rate for influenza viruses was 11.4%. It was highest in children 
aged 5─9 years (14.4%) and lowest in adults aged 45─64 years (7.5%). Among sARI 
cases, 14,536 (13.7%) cases were tested and 1,511 (10.4%) were positive for influenza 
viruses. The highest positive rate was observed in young adults aged 16─24 years 
(23.1%), and the lowest positive rate in children aged less than 5 years old (7.1%). Of 
those 16─24 years age group, the positive rates for A (H1N1)pdm09 were accounted for 
18.6%. In addition, a ratio of sARI to ILI was high among cases ≥60 years old, although 
the number of sARI cases in this age group was small.  
Predominant strains of influenza virus were varied between the seasons. A 
(H1N1)pdm09 was a predominant strain in the 2009/10 season, influenza B in the 
2007/8, 2011/12, and 2013/14 seasons, influenza A (H3N2) in the 2010/11, and 2012/13 
seasons and seasonal A (H1N1) in the 2008/9 season. 
Selected samples negative for influenza viruses from ILI and sARI cases from the 
2010/11 to 2013/14 seasons were tested for other respiratory viruses. Among sARI 
cases, RSV was a major causative virus in 2010/11 and 2011/12 whereas RV was in 
2012/13 and 2013/14. RSV positive rate was higher in hospitalized children less than 5 
years than outpatient cases. Among ILI episodes, RV was the most frequently detected 
virus.  
A plot of weekly number of influenza positives showed a clear seasonal pattern of 
influenza nationwide. Typically, first influenza cases were detected from late October to 
early January and reached a peak in February. The temporal trends of sARI cases were 
slightly different from those of the ILI. Two peaks were generally observed during each 
season; the first peak occurred in between October and December and the second one 
between January and March. The first peak was contributed by cases in all age groups, 
but in the second peak, there was a slight increase of sARI cases in children aged less 
than 5 years. During the second peak of the 2009/10 season, influenza B was the main 
influenza virus detected and had more sARI cases than in the first peak of 2009/10 
season, in which A (H1N1)pdm09 was a dominant influenza virus. 
The distribution of influenza positives in a map showed the synchronization of 
predominant strains across aimags in the seven consecutive seasons except the 
2013/14 season. In general, influenza B was the dominantly circulating strain in three 
seasons: 2007/8, 2011/12 and 2013/14. In 2007/8 an influenza B was the most 
commonly detected virus and influenza A (H3N2) was co-circulated. In 2011/12 season, 
influenza B cases were not detected in only one aimag out of seven aimags. In 2008/9 
and in 2010/11 season influenza A (H1N1) (except one aimag out of seven) and the 
dominantly circulating strain was A (H3N2). In 2009/10 influenza A (H1N1)pdm09 was 
the dominant and influenza A (H3N2) was the predominant strain in 2012/13 season. In 
2013/14 influenza B, A (H1N1)pdm09 and A (H3N2) were co-circulated with higher 
intensity of influenza A (H1N1)pdm09.  
In summary, this study highlights that in Mongolia, influenza viruses as well as other 
respiratory viruses like RSV and RV contributed to a significant burden in both ILI and 
sARI children aged less than 5 years old.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Introduction 
Influenza viruses are highly infectious and cause respiratory illness in human. Influenza 
illness extends from mild disease to serious complications such as pneumonia especially 
in elderly and young children resulting in substantial disease burden (1-3). Influenza 
causes seasonal epidemics because of continuous antigenic changes by mutations in 
the antigenic sites of circulating seasonal influenza viruses, so called antigenic drift. 
Furthermore, antigenic shift, another mechanism of antigenic change, is also 
responsible for epidemics of influenza viruses. Antigenic shift occurs through 
introduction of an antigenically distinct virus in the human population. Those 
antigenically distinct viruses have a potential to cause a widespread global epidemic 
with high morbidity and mortality. Seasonal influenza epidemics usually occur during the 
winter in temperate climates, but influenza can be observed throughout the year in the 
tropics (4). The epidemiology and impact of influenza are well defined in high income 
countries in temperate regions. Although more data from countries in different settings 
including those in tropical and subtropical climate became available in recent years (5-
11), the data from developing countries are still limited (12, 13). Influenza control is not 
prioritized in many developing countries partly because there is no appropriate data to 
define epidemiology and impact of influenza. Therefore influenza control programs 
including vaccination are not fully implemented in most developing countries (14, 15). 
The seasonality of human influenza varies by region. In temperate region of northern 
hemisphere, influenza transmission appears in winter. Influenza season could start as 
early as October, and usually peaks in January or February. The distinct seasonality 
enables to allocate the resources at appropriate time, thereby facilitating implementation 
of public health interventions to minimize the impact associated with influenza (10). The 
influenza activity can be measured by the trend of ILI cases and positive rate for 
influenza viruses. The peak influenza activity is generally defined as the month with the 
maximum percentage of respiratory samples positive for influenza viruses (16). 
Influenza disease burden is considered to be significant throughout the world as the 
disease causes high morbidity and significant mortality in humans. Influenza disease 
burden is usually measured by mortality, morbidity and economic loss. Costs associated 
with influenza infection due to human suffering are immeasurable, and the economic 
costs are quite high. For instance, in Germany and France the cost of health care 
services related to influenza was estimated at US $300 million, and in the United States, 
the direct cost of influenza was reported at US $1─3 billion per year (17). According to 
the World Health Organization (WHO), every year 5%–10% of adults and 20%–30% of 
children become infected with influenza viruses and on average, 250,000 to 500,000 
individuals die from complications associated with influenza (18). The importance of 
defining the disease burden associated with influenza has been recognized (19). The 
methods to estimate disease burden, especially mortality impact, have been well 
established in developed countries. The prevalence and burden of influenza have been 
described for the temperate countries in both northern and southern hemispheres (15, 
20-24). In those countries the seasonal peaks of influenza occur distinctly during the 
cold seasons (22, 25, 26). As aforementioned, typically elderly people and children aged 
less than 5 years have the highest influenza mortality, therefore vaccination programs 
mainly focus on these age groups in most countries (21, 23, 27, 28). Monitoring the 
incidence and clinical characteristics of influenza and hospitalization due to influenza is 
also critical in understanding the influenza disease burden in the population and guiding 
prevention and control strategies. However, there remains limited information regarding 
the impact of influenza including clinical manifestation and outcome of hospitalization of 
influenza cases in different contexts particularly in developing countries, including 
Mongolia.  
The Mongolian influenza surveillance system has been developed and improved 
gradually over the last four decades overcoming many obstacles and challenges. 
Several studies on epidemiology of influenza in Mongolia have been previously 
published (6, 29, 30). The study conducted on influenza disease burden in a local 
Mongolian community showed a significant burden of influenza during the influenza 
season, and the incidence of ILI was particularly high in children aged less than 5 years 
(29). However, the study was limited by the scope of the population. Therefore, this 
study was conducted to define the epidemiological characteristics and disease burden of 
influenza in whole Mongolia using the more comprehensive national surveillance data 
and samples collected from patients who visited outpatient clinics with ILI and 
hospitalized patients with sARI.  
 
2.1. Geographic and climatic background 
Mongolia is a landlocked country located in Northeast Asia between the latitudes of 
41035”N and 52009”E and longitudes of 87044”N and 119056”E (Figure 2). The country is 
bordering in the North with the Siberian part of the Russian Federation and in the East, 
West and South with the People’s Republic of China. Mongolia is the seventh largest 
country in Asia and the nineteenth largest in the world. Mongolia has a huge landscape 
of over 150 million hectares. The country is divided into 21 provinces, locally called 
aimags. The climate of Mongolia is extreme with four distinct seasons. Average annual 
temperatures range between 8.50C in Gobi and -7.80C in the high mountainous areas. 
The minimum temperature is usually between -310C and -52.90C in January, and the 
maximum temperature ranges from +28.50C to +42.20C in July (31). 
 
2.2. Demography and main health indicators of Mongolia 
Population growth rate in Mongolia has been gradually increasing in recent years; 
however, the population density is still one of the lowest in the world. Despite such low 
population density, influenza transmission has been occurring every year (32). At the 
end of 2013, the population of Mongolia reached 2 930 300, of which 48.7% were male 
and 51.3% were female. The percentage of population aged less than 15 years was 
27.4%, aged 15─64 years was 68.8% and aged 65 years and older was 3.8%. 
According to the latest report from the Center for Health Development of the Ministry of 
Health (CHD, MoH), Mongolia in 2013, the life expectancy at birth is 69.1 years, infant 
mortality rate is 14.6 per 1000 live births, under 5 mortality rate is 18.0/1,000 live births, 
and maternal mortality rate has been decreasing steadily since 2000, and it reached the 
lowest level of 42.6/100,000 live births in 2013 (33). Respiratory diseases including 
acute respiratory infections are the leading cause of morbidity in general population, 
especially in children.  
 
2.3. Health Service Delivery in Mongolia 
Mongolia has a mix with governmental and private health care system with dominating 
government health institutions at three levels: primary, secondary and tertiary. Mongolian 
health care system consists of a total 45,000 employees including 8,911 medical doctors 
(30.7/10,000 population), and 27,552 middle level health personnel including nurses, 
doctor’s assistants, laboratory technicians (60/10,000 population) and has relatively 
good health personnel supply among developing countries (33). Health services in 
private sector are still limited and expensive. Moreover, private health services are 
mostly located in urban areas.  
 
2.4. Influenza Surveillance System in Mongolia 
Influenza and other acute respiratory infections have been a serious public health 
concern in Mongolia since the 1970s because of rapidly growing population as well as 
urbanization. The National Influenza Center (NIC) in Mongolia was established in 1974, 
and joined the Global Influenza Surveillance Network (GISN) in 1978. The system was 
hugely affected by economic constraints in 1990s due to political and economic 
transitions in the country. The influenza surveillance system has begun to restore after 
the initiation of cooperative agreement between the Centers for Disease Control and 
Prevention (CDC), the United States (US) and NIC, Mongolia. Since then, the system 
has gradually improved its quality and coverage to meet the requirements of the WHO 
for the NIC designation. Influenza surveillance in Mongolia is currently coordinated by 
the NIC. Until 2004 ILI surveillance was conducted only from October 1 to June 30 and 
based only on weekly phone reporting of ILI incidences among outpatient visits in 
Ulaanbaatar, the capital city and 21 aimag centers (provincial capitals). After introducing 
the new influenza surveillance system in 2004/5 season, the NIC had increased the 
number of sentinel surveillance sites to a total of 155 sentinel sites by October 2009 (32). 
From 2006/7 season, sARI surveillance with 15 sentinel sites was included in the 
surveillance system, which has been gradually extended to cover all provincial hospitals, 
district hospitals, the large hospitals, and national centers in Ulaanbaatar consisting of 
37 sites, which have been covering the entire country since 2009/10. The Mongolian 
surveillance sites are divided into three categories by frequencies of specimen collection. 
The first category of influenza surveillance sentinel sites (ISSSs) reported ILI and sARI 
cases weekly and required collection of nasopharyngeal swabs from 5─10 patients with 
ILI and sARI per site and per week for the entire year. During peak influenza seasons, 
most of these sites collected specimens twice a week. The second category of ISSSs 
reported ILI and sARI cases weekly, but collected samples from patients only if there 
was a cluster or an unusual increase in the number of cases. The third category of 
ISSSs reported ILI and sARI cases weekly, but samples were collected only through 
consultation with the NIC and when the ILI rates exceeded a particular level. ILI 
surveillance has been conducted all year round since 2006/7 season including hospital 
based surveillance of pneumonia and sARI events in response to emergence of serious 
public health concern such as pandemic influenza in 2009 and other influenza and other 
respiratory diseases outbreaks. 
 
 
 
 
 
 
 
 
 
 
 
3. Objectives 
3.1. General Objective 
To understand the disease burden and epidemiological characteristics of influenza in 
whole Mongolia  
 
3.2. Specific Objectives 
1) To measure the incidence rates for ILI (influenza like illness) and sARI (severe acute 
respiratory infection) cases in Mongolia; 
2) To calculate the positive rates of influenza and other respiratory viruses in Mongolia; 
3) To define the seasonality of influenza and other respiratory viruses in Mongolia; 
4)  To analyze the geographical distribution of influenza cases in Mongolia; 
5) To identify strengths and gaps of currently ongoing influenza surveillance system in 
Mongolia; 
 
4. Materials and Methods_ 
4.1. Study period  
From October 1, 2007 to September 30, 2014, which covered seven influenza seasons 
 
4.2. Study design  
This was a prospective longitudinal study by analyzing the data from ongoing national ILI 
and sARI surveillance in Mongolia. 
 
4.3. Study procedures 
In this study, both the weekly ILI and sARI surveillance data from the 2007/8 to 2013/14 
influenza seasons were included. The surveillance data consists of number of patients 
with ILI and total visits to outpatient clinics, the number of patients with sARI and total 
admissions to hospitals, the number of laboratory confirmed influenza cases by virus 
type/subtype and the number of specimens tested. The detailed flow chart of study 
designs including data collection procedure is shown in Figure 1. The epidemiological 
and laboratory data were entered by ISSSs using a web based online database system.  
The entire database was centrally maintained by NIC, Mongolia. 
In order to analyze the influenza disease burden and spatio-temporal patterns of 
influenza transmission dynamics, ISSSs were selected based on the following criteria:  
1) Ability to collect specimens regularly, usually 1─2 times per week year round;  
2) Comprehensive surveillance data collection by the sentinel sites;  
3) Representing different geographic regions for better coverage;   
4) Regions with high population density;  
5) Along main railway route, this represents majority of the population (about 64.2% of 
total population during the study period);  
It is noteworthy to mention that geographically Mongolia lies in a quite interesting setting 
with only three main entry points into the country: Ulaanbaatar (by air), Selenghe 
(Russian border, by train), and Dornogobi (Chinese border, by train). The ISSSs included 
in the analysis were located in the following aimags: Dornogobi in the south-eastern 
region, Dornod in the eastern region, Khovd in the western region, Selenghe in the 
northern region, and Uvurkhangai, Orkhon, Darkhan-Uul and Ulaanbaatar in the central 
region (Figure 2). The socio-demographic data including age-stratified population data in 
each year was obtained from aimags to calculate the incidence rates. The summary of 
such data was reported annually by the CHD, MoH (33). 
4.4. Case definitions 
ILI and sARI cases were defined based on the WHO standard case definitions 
recommended before January, 2014. The ILI and sARI case definitions were as follows:  
ILI case is a person with sudden onset of fever (≥38.0°C), cough, and sore throat in the 
absence of another diagnosis. sARI case is a patient with ILI and shortness of breath or 
difficulty breathing, requiring hospitalization. 
 
4.5. Laboratory methods 
The most of laboratory tests for influenza viruses were conducted by the Virology 
Laboratory (VL) of the NIC, Mongolia. About 3% of samples were tested in branches of 
VL established in Darkhan-Uul and Orkhon aimags in 2010. In each sentinel hospital 
(either out- or in-patient) nasopharyngeal swabs were collected from 5─10 patients with 
ILI and sARI per site and per week for the entire year. During the peak influenza 
seasons, most of these sites collected samples twice per week. The collected 
specimens were immediately immersed into a sterile tube containing virus transport 
medium and stored in refrigerator at the sentinel sites. The samples were transported to 
the VL of the NIC or a branch laboratory once per week. Commonly, the frequency of 
sample collection increased during the winter months. Samples were usually shipped by 
car from the central region, by plane from the western and eastern regions, and by train 
from the northern and southeastern regions.  
The samples were inoculated on Madin-Darby Canine Kidney (MDCK) cells or 
embryonated hen’s eggs to isolate the influenza viruses during the 2007/8 and 2008/9 
seasons. The type/subtype of influenza virus was detected by reverse transcription-
polymerase chain reaction (RT-PCR) and the hemagglutination inhibition (HI) test. The 
reagents for the HI test were provided by WHO Collaborating Centers (CCs); National 
Institute of Infectious Diseases (NIID), Tokyo, Japan and the CDC, Atlanta, GA, USA. 
Real time (rt)-RT-PCR assays were performed to detect influenza viruses in selected 
samples from August in 2008. This testing procedure was routinely done for all samples 
received at the NIC since August 2009. All assays were performed following the 
standard protocol originally developed by the CDC (34), and primers were provided by 
WHO CCs. Influenza A positive specimens were further subtyped using specific rt-PCR 
for seasonal A (H1N1), A (H3N2), and A (H1N1)pdm09. For the isolation of viruses, 
those influenza positive specimens by rt-RT-PCR were inoculated on MDCK cells using 
a standard protocol (35). To detect other respiratory viruses, multiplex rt-PCR was done 
for selected samples with influenza negative results started in the 2010/11 season using 
commercially available multiplex PCR kits (FTD Respiratory Pathogens 21; FTD 
2─96/12; Fast-track Diagnostics, Junglinster, Luxembourg). Selected influenza virus 
isolates were sent to the WHO CC in Tokyo, Japan, for further analyses. 
 
4.6. Statistical analyses 
The proportion of specimens positive for influenza virus was calculated for each week. 
The incidence rates of ILI and sARI were calculated as the proportion of ILI and sARI 
cases to the total population in the area covered by surveillance. In this study, the peak 
period of influenza season was defined as the time when the number of ILI cases 
exceeded a threshold, and the influenza virus positive rates exceeded 15% or more 
among total tested samples in a week. The threshold was calculated by the cyclic 
regression model, so called Serfling’s method (36) using nationwide data on ILI 
morbidity per 10,000 population from 2000 to 2011 in Mongolia.  
The maps were created with ArcGIS 10.1 (ESRI, CA, US). All calculations were 
performed using Microsoft Excel 2010 (Microsoft Corp., Redmond, WA) or R 3.1.2 (R 
foundation, Vienna, Austria). 
This study was approved by the Research Ethics Committees of the Mongolian 
Academy of Medical Sciences (MAMS), and the NIC, Ministry of Health, Ulaanbaatar, 
Mongolia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Results 
5.1. ILI cases 
During the seven influenza seasons from 2007/8 to 2013/14, a total of 35,572,137 
outpatient visits were recorded and 1,797,655 (5.1%) were diagnosed as ILI (Table 1).  
The ILI incidence rates per 100 population were calculated for each season. The overall 
ILI incidence rate was highest in the 2009/10 season (22.2 per 100 population), which 
was higher than the average incidence rate for the seven influenza seasons (14.6 per 
100 population). The incidence rates were similar to the average in the 2010/11, 
2011/12 and 2012/13 seasons; 14.7, 14.1 and 14.9 per 100 population, respectively. 
The ILI incidence rates were highest among those aged less than 5 years in the all 
seven seasons; the overall incidence rate in this age group was 86.0 per 100 population 
for the seven seasons, ranging from 60.1 in the 2008/9 season to 112.9 in the 2009/10 
season. The rates were lower in adult age groups with the lowest overall rate in the age 
group of 25─44 years (2.5 per 100 population). In all age groups, the rates were highest 
in the 2009/10 season, but difference between the 2009/10 season and the average for 
all seasons were larger in older age groups. The rates in the 2009/10 season were more 
than twice higher than the average in 16─24 years, 25─44 years, 45─64 years, and 65 
years or older. 
 
5.2. Detection of influenza and other viruses in ILI cases 
A total of 22,582 (1.3%) ILI cases were tested for influenza viruses and 2,577 were 
positive, including 228 (8.8%) of A (H1N1), 995 (38.6%) of A (H1N1)pdm09, 682 (26.5%) 
of A (H3N2) and 672 (26.1%) of influenza B (Table 2).  
On average 3,226 specimens (between 2,128 and 5,050) were tested annually for 
influenza viruses. Among those specimens, the overall positive rate for influenza viruses 
was 11.4%. The positive rates by season were ranging from 2.6% in the 2007/8 season 
to 28.4% in the 2009/10 season. Over the seven seasons, the total positive rate for A 
(H1N1), A (H1N1)pdm09, A (H3N2) and B viruses were 1.0%, 4.4%, 3.0%, and 3.0%, 
respectively (Table 2). 
The predominantly circulating strains varied between seasons. A (H1N1)pdm09 was a 
predominant strain in the 2009/10 season, during which 726 (76.8%) out of 945 
influenza virus positive cases were A (H1N1)pdm09. The A (H1N1)pdm09 positive rate 
was 21.8% in the 2009/10 season, however, this rate declined to 2.9%, 0.7%, 3.0%, and 
4.9% in the 2010/11, 2011/12, 2012/13 and 2013/14 seasons, respectively. Influenza B 
was the most commonly detected virus in the 2007/8, 2011/12, and 2013/14 seasons, 
influenza A (H3N2) in the 2010/11, and 2012/13 seasons and seasonal A (H1N1) was in 
the 2008/9 season (Table 2).  
The total influenza positive rates by age group ranged from 7.5% to 14.4%. It was 
highest in children aged 5─9 years (14.4%) and lowest in adults aged 45─64 years 
(7.5%) and ≥65 years (7.7%) (Table 3). Positive rates for different age groups differed by 
virus type/subtype: Positive rates for influenza A (H3N2) were highest (3.6%) among 
children aged less than 5 years; positive rates for influenza A (H1N1) were highest 
among children 5─9 and 10─15 years (1.3% for both); and positive rate for influenza B 
was also highest among children aged 5─9 years (4.9%). However, age distribution of 
influenza A (H1N1)pdm09 was significantly different, and the highest positive rate (8.4%) 
was observed among young adult aged 16─24 years. 
A total of 1,350 specimens negative for influenza viruses between 2010/11 to 2013/14 
seasons were selected and tested for other respiratory viruses. Of those specimens, 563 
(41.7%) were positive for at least one virus, including RV (139, 24.7%), hMPV (64, 
11.4%), RSV (45, 8.0%), and hPIV3 (31, 5.5%). The positive rate for hMPV was the 
highest among children aged 1─4 years and 5─9 years (6.5% for both), for hPIV3 it was 
highest in children aged less than 1 year (3.4%), for RSV higher rates were seen in 
children aged 10─15 years (5.3%), less than 1 year (5.2%) and 1─4 years (4.1%) and 
for RV the highest was in adults aged 16─24 years old (25.0%) (Table 4).  
Unlike other three respiratory viruses, RV has shown year-round circulation with two 
peaks before and after the increase in the influenza positive rates during the 2011/12, 
2012/13 and 2013/14 seasons (Figure 3). The positive rates of RV, hMPV, RSV, and 
hPIV3 in ILI cases were 10.3%, 4.7%, 3.3% and 2.3%; respectively. Among ILI episodes, 
RV was the most frequently detected virus throughout the four seasons (Table 5). 
ILI cases started increasing between October and November, peaked between 
December and February and resumed to baseline between April and May for the study 
period except the 2009/10 season when there were two peaks; one in October 2009 
which was caused by A (H1N1)pdm09 another peak in February 2010, which was 
caused by influenza B. Typically, the first influenza cases were detected in late October 
to early January and reached a peak in February (Figure 3).  
 
5.3. sARI cases 
During the study period, a total of 106,003 sARI patients were recorded, of which 84,618 
(79.8%) were aged less than 5 years and only 2,394 (2.3%) were aged 60 year or older 
(Table 6).  The overall sARI incidence rate for the seven seasons was calculated to be 
0.9 per 100 population. The overall sARI incidence rate was highest in the 2013/14 
season (1.2 per 100 population).  The incidence rates were lower in the 2007/8 and 
2008/9; 0.6 and 0.5 per 100 population, respectively. The rates were highest in those 
aged less than 5 years in all seasons with the overall rate of 6.9 per 100 population 
(ranging from 4.3 in the 2008/9 season to 9.0 in 2013/14 season). The rates were much 
lower in other age groups with the lowest rate in those aged 20─49 years. The rate was 
also generally low in those aged 60 years or older (0.3 per 100 population). Unlike the 
ILI incidence rate, the sARI incidence rate was not significantly higher in 2009/10 season.  
The temporal trends of sARI cases showed slightly different patterns from those of the 
ILI. Two peaks were generally observed during each season; the first peak occurred 
between October and December and the second one between January and March. The 
first peak was contributed by cases in all age groups, but in the second peak, there was 
a slight increase of sARI cases in children aged less than 5 years. During the second 
peak of the 2009/10 season, influenza B was the main influenza virus detected and had 
more sARI cases than in the first peak of 2009/10 season in which A (H1N1)pdm09 was 
a dominant influenza virus (Figure 5).  
 
5.4. Detection of influenza and other viruses in sARI cases 
A total of 14,536 (13.7%) sARI cases were tested for influenza viruses, and 1,511 
(10.4%) were tested positive, including 61 (4.0%) of A (H1N1), 862 (57.0%) of A 
(H1N1)pdm09, 291 (19.3%) of A (H3N2) and 297 (19.7%) of influenza B (Table 7). 
Among a total of 1,511 positive cases, 688 (45.5%) were aged less than 5 years old and 
only 18 (1.2%) were aged 65 years or older (Table 8). An average of 2,077 specimens 
(range: 1,569─3,499) were tested annually for influenza viruses. The highest positive 
rate was observed in the 2009/10 season, during which 802 (22.9%) of 3,499 samples 
were positive for influenza viruses including 685 (85.4%) of A (H1N1)pdm09 and 117 
(14.6%) of influenza B (Table 7). Over the seven seasons, the total positive rates for A 
(H1N1), A (H1N1)pdm09, A (H3N2) and B viruses in sARI cases were 0.4%, 5.9%, 2.0%, 
and 2.0% respectively.  
Although, number of positives for influenza viruses was highest in children less than 5 
years (688), the highest positive rate was observed in young adults aged 16─24 years 
(23.1%). Positive rates in different age groups varied by virus type/subtype: Positive rate 
for influenza A (H3N2) was  highest among adults aged 65 years or older (2.6%); that for 
influenza A (H1N1) was highest among children 5─9 years (0.7%); and that for influenza 
B was also highest among children aged 5─9 years (5.4%). Like ILI cases, the highest 
positive rate (18.6%) for A (H1N1)pdm09 was observed among young adults aged 
16─24 years (Table 8).  
A total of 1,682 specimens negative for influenza viruses were selected from the sARI 
cases from the 2010/11 to 2013/14 seasons to be tested for other respiratory viruses. Of 
these specimens, 763 (45.4%) were positive for at least one virus, including RV (145, 
19.0%), RSV (143, 18.7%), hMPV (85, 11.1%), and hPIV3 (45, 5.9%). A peak in RSV 
positive rates was observed during the second peak of the 2010/11 and first peak of the 
2011/12 season, when extremely low influenza positive rates occurred (Figure 6). The 
positive rates of RV, hMPV, RSV, and hPIV3 in sARI cases were 8.6%, 5.1%, 8.5% and 
2.7%; respectively (Table 9). For hMPV the positive rate was highest among children 
aged 1─4 years (6.5%); for hPIV3 it was highest in adults aged 45─64 (4.7%); for RSV 
higher rates were observed in infants and small children; 13.2% in those aged less than 
1 year and 8.5% in those aged 1─4 years; and for RV the highest was in adults aged 
45─64 years old (11.6%) (Table 9). Among sARI cases RV (8.6%) and RSV (8.5%) were 
the most commonly identified viruses.  
Among sARI cases the highest positive rate of RSV, RV, hMPV and hPIV3 was in 
2011/12, 2013/14, 2013/14 and 2010/11 with 12.5%, 10.5%, 6.8%, and 5.2%, 
respectively (Table 10). RSV positive rate was higher in hospitalized children less than 5 
years than outpatient cases.  
 
5.5. Spatio-temporal distribution of influenza positives 
Figure 7 shows the spatio-temporal distribution of influenza positives using proportion of 
positives of each virus type/subtype over total number of positives in the seven seasons.  
In 2007/8 influenza B virus was a predominant virus in all regions with co-circulation of 
influenza A (H3N2) in the south-eastern and central regions of the country. In the 
western, eastern and northern regions influenza A (H3N2) was not observed. In 2008/9 
seasonal A (H1N1) was dominated in all regions with the exception of Khovd aimag in 
the western region. In the central region, in Ulaanbaatar, Selenghe and Orkhon aimags 
influenza A (H3N2) was detected, and a few cases of influenza B were also detected in 
the capital city, Ulaanbaatar. In 2009/10 A (H1N1)pdm09 was introduced in all regions 
and reached a peak in short period of time, which was followed by spread of influenza B 
in all regions with the exception of Selenghe aimag in the northern region at the Russian 
border. In the central and in the south-eastern region, at the Chinese border 
transmission of influenza B was higher than in other regions. In 2010/11 influenza A 
(H3N2) was a dominant strain in all regions, co-circulating with influenza A 
(H1N1)pdm09 with more intense spread in Orkhon aimag. In the western and the 
eastern regions influenza A (H1N1)pdm was circulated with low intensity than in others. 
The epidemic was also contributed by influenza B in the central and in the south-eastern 
regions at the Chinese border. In 2011/12 influenza B was dominated with co-circulation 
of influenza A (H3N2). Influenza A (H3N2) spread was higher in Orkhon aimag than in 
others. Influenza A (H1N1)pdm09 was also seen in to Ulaanbaatar, Selenghe and 
Dornogobi aimags along the main Mongolian railway network. In 2012/13 influenza A 
(H3N2) was a dominant strain throughout the country with co-circulation of influenza A 
(H1N1)pdm09. Influenza A (H1N1)pdm09 was not seen in the western region and with 
low intensity in the eastern region. But co-circulation was almost at the same level by 
intensity in the central and south-eastern regions. In 2013/14 influenza season influenza 
A (H3N2), A (H1N1)pdm09 and influenza B were co-circulated in the country. Influenza B 
was predominantly circulated in the south-eastern and central regions, but influenza A 
(H1N1)pdm09 was a dominant strain in the western, eastern and in the central regions. 
Influenza B virus dominated in the northern region at the Russian border and in the 
south-eastern region at the Chinese border. 
In general, transmission of influenza viruses occurs in all regions of the country with 
different intensity during influenza epidemics. 
 
 
 
 
 
 
 
 
 
 
6. Discussion 
This was the first study attempting to define nationwide disease burden and 
epidemiological characteristics of influenza in Mongolia. To describe epidemiological 
patterns of influenza and virus circulation for whole Mongolia, ISSSs were selected by 
considering the proportion of population.  Seven provinces and Ulaanbaatar city were 
selected as ISSSs, which represent majority of the population (about 64.2% of total 
population) in the country. Despite a huge landscape, the ISSSs were selected from 
different geographic regions for better coverage and provinces that function as a hub for 
human traffic including those along main railway route and bordering provinces with 
Russia and China were also selected. Therefore, it is considered that the data of the 
study captured epidemiological patters of influenza in whole country.     
The overall ILI incidence rate was highest in the 2009/10 season, which was higher than 
the average rate for the seven influenza seasons. This was partly because more ILI 
cases intended to seek care at healthcare facilities during the pandemic of A 
(H1N1)pdm09. The sARI incidence rate in the 2009/10 season was also higher than the 
average rate although it was lower than that in the 2013/14 season. The impact of A 
(H1N1)pdm09 was clearly observed in ILI while that in sARI was compatible between A 
(H1N1)pdm09 and other influenza viruses. The highest incidence rate of sARI in 
2013/14 season was likely to be due to combining impact of three types/subtypes of 
influenza viruses: influenza B, A (H1N1)pdm09 and A (H3N2). This was the first season 
when the A (H1N1)pdm09 virus circulated predominantly after the 2009/10 pandemic 
period. This was also observed in other temperate countries (16). Influenza B was 
considered to cause a milder illness than influenza A viruses however, recent studies in 
China and Hong Kong indicated a high disease burden of influenza B (37, 38). This 
study showed a compatible positive rate between A (H3N2) and influenza B among sARI 
cases, which indicated a potential impact of influenza B in hospitalization.  
During the study period dominant influenza virus types/subtypes were varied between 
seasons, and the same virus type/subtype was not predominant for two consecutive 
seasons. Higher positive rates of influenza B virus were observed every two season: 
2007/8, 2009/10, 2011/12 and 2013/14 seasons. Similar pattern of influenza B virus 
circulation was reported from other countries, particularly in the northern hemisphere 
countries (6, 16).  
Age is a key determinant for ILI and sARI incidence rates and influenza positive rates. 
The highest ILI and sARI incidence rates were observed in children less than five years 
in the all seven seasons which were compatible with results of the population based 
study in Vietnam (39). However, influenza positive rate was highest among children 
aged 5─9 years in ILI cases which were similar to study results in China and 
Bangladesh (40, 41). Generally, 5─9 year age group represents the preschool and 
school age group and has a high social mixing (30, 42). A community-based study in 
Mongolia (29, 43) and other countries (44-47) have also reported the highest incidence 
in young children including infants. The ILI incidence rate among the adult population 
was low but it was higher in the 2009/10 season. This increase could be explained partly 
due to the large number of susceptible population to the novel influenza virus in adults 
and partly due to the change of health seeking behavior because of anxiety among 
general public during that period.  
The influenza virus positive rates for both ILI and sARI were lower for the 2007/8 and 
2008/9 seasons because screening for influenza viruses was conducted by viral 
isolation during these two seasons, which is less sensitive than detection methods used 
later. After introducing rt-PCR as the initial screening method during the 2009/10 
influenza season, the influenza virus positive rates significantly increased, as was also 
noted in the study in Thailand (48). Among sARI cases, the overall highest influenza 
positive rate (23.1%) was observed in young adults aged 16─24 years, which was 
compatible to other study results (49, 50). This highest positive rate was due to A 
(H1N1)pdm09 since 81% of influenza positives in this age group were that subtype. 
When excluding A (H1N1)pdm09 positives during the pandemic period, the rate went 
down to 12.7%. The second highest positive rate was found in children 10─15 years. 
Although the number and the incidence rate of sARI cases were highest in children aged 
less than 5 years, influenza positive rate was lowest (7.1%) in this age group. 
In addition, a higher ratio of sARI to ILI was found among persons more than 60 years 
old, although the number of sARI cases in that age group was low. The higher proportion 
of sARI among the elderly reflects more severe influenza infection in this age group, 
which is similar to other countries where severe complications are reportedly more 
common in elderly people (21, 51, 52). But, no apparent excess mortality was estimated 
in Mongolia by using the Serfling type model with 2004-2007 surveillance data (53). This 
may partly be because the elderly population, which occupies a major part of influenza 
excess mortality, is smaller in developing countries, including Mongolia. 
ILI and sARI specimens were selected for testing other respiratory pathogens for the 
2010/11 to 2013/14 seasons. The results indicated that among ILI episodes, RV was the 
most frequently detected virus throughout the four seasons, whereas among sARI cases, 
RV and RSV were more commonly identified viruses. Similar to our data the study in 
China which tested all samples for other respiratory viruses found that RV was also the 
most frequently identified virus and followed by hMPV and RSV (54). RSV positive rate 
was higher in hospitalized children less than 5 years than in outpatient cases. This 
finding is in line with other studies, which recognized RSV as significant viral etiology of 
severe acute respiratory infection in infants and young children (55-57). The increase of 
ILI activity before and after influenza virus circulation may be due to other respiratory 
viruses, including RSV, hMPV, or hPIV3. Some other study results showed that these 
three viruses have seasonal epidemic peaks in children (58) which were similar to our 
results. Also, a recent study reported that PIV, RSV, and hMPV cause outbreaks twice 
per year (one peak between October and December and another peak between March 
and May) in Mongolia (59). RSV had a considerably higher positive rate than influenza in 
sARI cases, as observed in other studies (60). This reflected the facts that most sARI 
cases in the present study were observed in small children. Unlike RSV, hMPV, and 
hPIV3, RV has shown year-round circulation with two peaks before and after the peaks 
of influenza positive rates during the 2011/12, 2012/13 and 2013/14 seasons. According 
the pathogens testing, other respiratory viruses occurred in all age groups. The 
observed high rates of other respiratory viruses among children aged less than 5 years, 
are important for clinical management since the viruses often correlates to severe illness 
as reported in other studies (29, 30, 43-47, 54).  
During the study period, the average number of samples tested for influenza for both ILI 
and sARI episodes was 5,304 annually with most intense sampling in Ulaanbaatar 
(3,570 samples per season) and lowest sampling in Dornod aimag in Eastern of 
Mongolia (76 samples per season) and on average, 584 influenza virus positive 
specimens were identified annually. The existing surveillance is representative and 
robust in nature as the weekly reporting system, sampling method, year-round 
surveillance in the inpatients and outpatients, quarterly assessment of ISSSs using the 
indicators, conducting the monthly audio-conference with ISSSs, timeliness, 
completeness and consistency of surveillance data. 
Influenza epidemics exhibit a distinct seasonality in temperate regions with extensive 
transmission typically occurring during the colder months; November–March in the 
northern hemisphere and May–September in the southern hemisphere (61, 62). This 
study has revealed that Mongolia has a clear seasonal pattern of influenza nationwide. 
Typically, the first influenza cases were detected in late October to early January and 
reached a peak in February. The positive rate for influenza viruses declined from late 
March to April, influenza virus circulation was lasting for average of 10 weeks per 
season in the seven studied seasons. ILI activities followed a similar seasonal pattern of 
influenza. Recently, some study results were reported changes in frequency and 
seasonality of influenza and other respiratory diseases (63, 64). In the study in 
Tennessee, the United States, when there was an increase in other respiratory viruses 
such as hMPV, RSV and RV detected, level of influenza virus activity was significantly 
lower. It is hypothesized that increases in other viruses can interfere with spread of 
influenza (64). However, opposite explanation may be possible that lower rates of 
influenza may allow other respiratory viruses to increase. Interaction between influenza 
and other respiratory viruses might be influenced by factors such as viral antigenicity 
and specific herd immunity. This year-round influenza surveillance enables to present a 
clear seasonality of influenza in Mongolia. Despite the comparatively high cost to sustain 
the existing surveillance system for ensuring year-round surveillance including sample 
transportation by air and train from different regions, regular laboratory supplies, and 
training of personnel, this type of surveillance system is useful in obtaining a complete 
picture of the influenza activity. It also contributes to early detection of outbreaks. As an 
outcome of this type of surveillance system, it was discovered that other respiratory 
viruses were predominant during early influenza seasons or after declining influenza 
activity.  
Despite such a sparse population density in a large territory, influenza transmission 
occurs throughout Mongolia. This study analyzed geographic spread of influenza viruses 
in the country during influenza epidemics in the seven seasons. In the central, south-
eastern and northern regions the proportion of influenza viruses was higher than the 
western and eastern regions, respectively. During the 2009/10 whole country including 
the seven aimags and Ulaanbaatar city experienced a rapid spread of influenza A 
(H1N1)pdm09. In 2009/10 as a second peak influenza B circulated in the country with 
high intensity in the central and south-eastern regions. In south-eastern region influenza 
viruses were detected in the all seven seasons with higher intensity than those in other 
regions with the exception of the central region, particularly, Ulaanbaatar city. This result 
might be due to population density, high social mixing and movement of population in 
this area using the main railway connected to the China and Russia. 
In Mongolia people commonly use coal-stove to keep them warm during winter months. 
This type of stove emits a large amount of smoke in the surrounding environment. This 
might be one of environmental factors that may increase the occurrences of respiratory 
diseases in children as well as in adults (65, 66). On the other hand, to define the 
association between influenza activity and weather parameters such as absolute 
humidity, sunshine, and precipitation more data are needed to assess the impact of 
human behavior and influenza virus transmission in different climates (4, 67, 68). As 
suggested in some other studies, influenza epidemics can be influenced by factors such 
as seasonal crowding, and influenza virus survival in respiratory droplets (69). Further 
studies are therefore needed to figure out the association of influenza disease with the 
particular climatic factors of Mongolia.  
There are several limitations in the current study. Firstly, even though the weekly ILI and 
sARI data from seven provinces together with Ulaanbaatar city were included, sample 
collection was conducted in selected sentinel sites and frequencies of sampling were 
varied both by places and the timing of influenza activity. However, I believe that the 
study results represent influenza circulation patterns in whole country. Secondly, the 
current surveillance system targeted selected healthcare facilities that might not reflect 
an entire picture of influenza activity in the community because some patients, 
especially adult patients with ILI or sARI may not seek care at healthcare facilities. 
Thirdly, tests for other than influenza viruses were conducted with selected samples 
negative to influenza virus. This potentially led a selection bias of samples tested as well 
as failed to detect co-infections. Lastly, a rather longer duration between sample 
collection and test led to a false negative result when samples were collected in a later 
course of the illnesses and transferred to the laboratory, however I believe this was 
surely minimal partly because samples were not collected if that duration was over 7 
days and there was a chance to select more fresh samples among many cases. Despite 
of those limitations, a systematic surveillance study with eight sentinel sites over 
Mongolian territory was established to provide a comprehensive data of ILI and sARI 
with testing influenza and other respiratory viruses in this study.  
 
 
 
 
7. Conclusion 
My study results showed as follows: 
First, the study shows the substantial disease burden due to influenza in ILI and sARI 
cases reported from sentinel sites throughout the study period. Like other previous 
studies, age was the key determinant, and the highest ILI and sARI incidence rates were 
observed in children less than five years in the all seven seasons.  
Second, despite the differences in frequencies of sample collection, sample size, and 
non-strict standardized criteria on sampling from patients with ILI and sARI in different 
regions, the study result shows the impact of not only influenza viruses but also that of 
other respiratory viruses, which also contributed significant disease burden. Among ILI 
cases, RV was the most frequently detected virus, affecting mainly adult population, 
whereas among sARI cases higher RSV positive rates were observed in infants and 
small children. Co-circulation of other respiratory viruses with influenza viruses was seen 
only when influenza positive rates were lower or before or after the decreasing the 
influenza positives. The study also indicates the clear seasonality of influenza in 
Mongolia. Samples were collected from seven geographically distinct aimags and the 
highest populated capital city Ulaanbaatar, in which around 64.2% of total population of 
Mongolia live. Therefore my data generally represents the whole Mongolia.  
Third, my study attempted to analyze the spatio-temporal distribution of influenza 
positives using the geographical method which also suggests the transmission of 
influenza virus occurs in all regions with different intensities during the annual epidemics.  
To date, there have already been several published studies focusing on the 
epidemiology of influenza in Mongolia (6, 29, 30), however, these studies were limited 
by the few study sites as well as by the small number of collected samples.  
As aforementioned, understanding the disease burden and epidemiology of influenza is 
important and the detection of epidemics is crucial in order to make proper decisions by 
policy makers and public health specialists, which include vaccination strategies. In this 
regard, my study will contribute in formulating the national vaccination policies. The 
study results suggest interventions targeting young children may be important to reduce 
influenza associated burden. On the other hand, to reveal a precise disease burden of 
influenza in Mongolia there is a need to improve the data quality including collection of 
detail information related to clinical manifestation and outcome of patients in the sentinel 
sites. 
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9. Figures   
Figure 1. Flow chart of study steps including data collection procedure* 
 
*ISSSs; Influenza Surveillance Sentinel Sites, ILI; Influenza-like Illness, sARI; severe Acute Respiratory Infection 
Figure 2. Map of Mongolia and location of sentinel sites for influenza surveillance * 
 
*UB; Ulaanbaatar 
 
 
 
 
Figure 3. Temporal distribution of (A) ILI cases and influenza-positive rates for ILI cases and (B) detected influenza 
viruses from ILI cases during the 2007/8–2013/14 seasons in Mongolia 
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Figure 4. Temporal distribution of ILI cases and positive rates for (A) influenza, and (B) hMPV, hPIV3, RSV and RV 
during the 2010/11–2013/14 seasons in Mongolia 
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Figure 5. Temporal distribution of (A) sARI cases and influenza-positive rates for sARI cases and (B) detected 
influenza viruses from sARI cases during the 2007/8–2013/14 seasons in Mongolia 
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Figure 6. Temporal distribution of sARI cases and positive rates for (A) influenza, and (B) hMPV, hPIV3, RSV and 
RV during the 2010/11–2013/14 seasons in Mongolia 
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Figure 7. Proportion of each influenza type/subtype over total positives in 7 seasons in Mongolia 
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Table 1. Number of influenza like illness (ILI) cases and incidence rates by influenza season and age group during 
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Table 2. Number of influenza positives, positive rates and proportion of influenza virus positive samples among 
total influenza positives by season for influenza like illness (ILI) cases in Mongolia during the 2007/8─2013/14 
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Table 3. Number of influenza positives and positive rates for influenza by age group for influenza like illness (ILI) 
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Table 4. Number of hMPV, hPIV3, RSV and RV positives and positive rates for influenza like illness (ILI) cases by 
age group during the 2010/11─2013/14 seasons in Mongolia 
 
 
 
 
Table 5. Number of hMPV, hPIV3, RSV and RV positives and positive rates for influenza like illness (ILI) cases by 
season during the 2010/11─2013/14 seasons in Mongolia 
 
 
 
 
 
 
 
 
Table 6. Number of severe acute respiratory infection (sARI) cases and incidence rates by influenza season and 
age group during the 2007/8─2013/14 seasons in Mongolia 
 
 
 
 
 
Table 7. Number of influenza positives, positive rates and proportion of influenza virus positive samples among 
total influenza positives by season for severe acute respiratory infection (sARI) cases in Mongolia during the 
2007/8─2013/14 seasons 
 
 
 
Table 8. Number of influenza positives and positive rates for influenza by age group for severe acute respiratory 
infection (sARI) cases in Mongolia during the 2007/8─2013/14 seasons 
 
 
 
 
Table 9. Number of hMPV, hPIV3, RSV and RV positives and positive rates for severe acute respiratory infection 
(sARI) cases by age group during the 2010/11─2013/14 seasons in Mongolia 
 
 
 
 
Table 10. Number of hMPV, hPIV3, RSV and RV positives and positive rates for severe acute respiratory infection 
(sARI) cases by season during the 2010/11─2013/14 seasons in Mongolia 
 
 
 
 
 
